01:06 , Mar 15, 2016 |  BC Extra  |  Company News

Stanford launches microbiome center

Stanford University 's Institute for Immunity, Transplantation and Infection said it launched the Center for Human Microbiome Studies. The center was seeded with funding from Stanford alumnus Paul Klingenstein, the founding managing partner of Aberdare...
07:00 , Apr 22, 2013 |  BioCentury  |  Finance

Legal tracks

Legal tracks Wendy Goldstein joined...
23:26 , Aug 28, 2012 |  BC Extra  |  Financial News

Rock Health startups to receive $100,000 investments

Healthcare IT incubator Rock Health said startups accepted into its program will now each receive a $100,000 investment. Aberdare Ventures; Kleiner Perkins Caufield & Byers; the Mayo Clinic; and Mohr Davidow Ventures are providing the...
07:00 , Apr 16, 2012 |  BioCentury  |  Finance

KAI makes lemonade

KAI Pharmaceuticals Inc. turned an undesirable side effect in an unsuccessful program into a lead candidate that led to a $315 million acquisition by Amgen Inc. (NASDAQ:AMGN) - and a 5x return for venture investors....
07:00 , Mar 19, 2012 |  BC Week In Review  |  Financial News

HemaQuest financial update

HemaQuest raised $13 million in an extension of a series B round, bringing the total raised in the round to $29 million. Existing investors Aberdare Ventures; De Novo Ventures; Forward Ventures; Latterell Venture Partners; and...
00:18 , Mar 13, 2012 |  BC Extra  |  Financial News

HemaQuest raises $13M in series B extension

HemaQuest Pharmaceuticals Inc. (San Diego, Calif.) raised $13 million in an extension of a series B round, bringing the total raised in the round to $29 million. Existing investors Aberdare Ventures; De Novo Ventures; Forward...
08:00 , Jan 2, 2012 |  BC Week In Review  |  Financial News

Aviir completes venture financing

Aviir Inc. , Palo Alto, Calif.   Business: Diagnostic, Cardiovascular   Date completed: 12/19/11   Type: Venture financing   Raised: $10 million   Investors: Merck Global Health Innovation Fund; Bay City Capital; Aberdare Ventures; New...
08:00 , Nov 7, 2011 |  BioCentury  |  Finance

Clovis closes in

Clovis closes in...
07:00 , Jun 27, 2011 |  BioCentury  |  Finance

In the clover

In the clover VCs have put $75.5 million into Clovis Oncology Inc. - a little more than half of the $145 million series A round originally committed after the company was formed in April 2009....
07:00 , Jun 27, 2011 |  BioCentury  |  Finance

What to do with $101M

Last week's $101M tranched series B round for oncology play Tesaro Inc. is expected to get the company to NDA submission for its lead candidate, in-license up to two additional compounds and advance a preclinical...